FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998461265> ?p ?o ?g. }

• W1998461265 endingPage "1101" @default.
• W1998461265 startingPage "1096" @default.
• W1998461265 abstract "Novel agents have demonstrated enhanced efficacy when combined with other antimyeloma agents especially dexamethasone. The steroid doses employed in myeloma regimens are often poorly tolerated. Therefore, in a phase II clinical trial we investigated the efficacy of a steroid-free combination including bortezomib, pegylated liposomal doxorubicin and thalidomide (VDT regimen). Twenty-three patients with relapsed or refractory myeloma or other plasma cell cancers were treated with the VDT regimen. Patient had a median of five prior therapies and 65.2% were refractory to their last regimen. The overall response rates were 55.5% and 22%, respectively. The median progression free survival was 10.9 months (95% CI: 7.3-15.8) and the median overall survival was 15.7 months (95% CI: 9.1-not reached). Fatigue and sensory neuropathy were the most common side effects noted. We observe that VDT is an effective steroid-free regimen with ability to induce durable remission even in patients with refractory myeloma." @default.
• W1998461265 created "2016-06-24" @default.
• W1998461265 creator A5004865099 @default.
• W1998461265 creator A5006011014 @default.
• W1998461265 creator A5010286156 @default.
• W1998461265 creator A5013824370 @default.
• W1998461265 creator A5019624678 @default.
• W1998461265 creator A5025865972 @default.
• W1998461265 creator A5035939523 @default.
• W1998461265 creator A5044589378 @default.
• W1998461265 creator A5052003560 @default.
• W1998461265 creator A5052202483 @default.
• W1998461265 creator A5057890851 @default.
• W1998461265 creator A5063296413 @default.
• W1998461265 creator A5064783396 @default.
• W1998461265 creator A5077133890 @default.
• W1998461265 date "2009-01-01" @default.
• W1998461265 modified "2023-09-27" @default.
• W1998461265 title "Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial" @default.
• W1998461265 cites W1987458494 @default.
• W1998461265 cites W2007389303 @default.
• W1998461265 cites W2021954218 @default.
• W1998461265 cites W2060420860 @default.
• W1998461265 cites W2096207943 @default.
• W1998461265 cites W2107154392 @default.
• W1998461265 cites W2108235071 @default.
• W1998461265 cites W2117172636 @default.
• W1998461265 cites W2119584679 @default.
• W1998461265 cites W2124560610 @default.
• W1998461265 cites W2127760782 @default.
• W1998461265 cites W2148188974 @default.
• W1998461265 cites W2148216137 @default.
• W1998461265 cites W2152065071 @default.
• W1998461265 cites W2166043738 @default.
• W1998461265 cites W2301776058 @default.
• W1998461265 cites W3145716452 @default.
• W1998461265 doi "https://doi.org/10.1080/10428190902912460" @default.
• W1998461265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19479618" @default.
• W1998461265 hasPublicationYear "2009" @default.
• W1998461265 type Work @default.
• W1998461265 sameAs 1998461265 @default.
• W1998461265 citedByCount "24" @default.
• W1998461265 countsByYear W19984612652012 @default.
• W1998461265 countsByYear W19984612652013 @default.
• W1998461265 countsByYear W19984612652014 @default.
• W1998461265 countsByYear W19984612652017 @default.
• W1998461265 countsByYear W19984612652018 @default.
• W1998461265 crossrefType "journal-article" @default.
• W1998461265 hasAuthorship W1998461265A5004865099 @default.
• W1998461265 hasAuthorship W1998461265A5006011014 @default.
• W1998461265 hasAuthorship W1998461265A5010286156 @default.
• W1998461265 hasAuthorship W1998461265A5013824370 @default.
• W1998461265 hasAuthorship W1998461265A5019624678 @default.
• W1998461265 hasAuthorship W1998461265A5025865972 @default.
• W1998461265 hasAuthorship W1998461265A5035939523 @default.
• W1998461265 hasAuthorship W1998461265A5044589378 @default.
• W1998461265 hasAuthorship W1998461265A5052003560 @default.
• W1998461265 hasAuthorship W1998461265A5052202483 @default.
• W1998461265 hasAuthorship W1998461265A5057890851 @default.
• W1998461265 hasAuthorship W1998461265A5063296413 @default.
• W1998461265 hasAuthorship W1998461265A5064783396 @default.
• W1998461265 hasAuthorship W1998461265A5077133890 @default.
• W1998461265 hasConcept C121332964 @default.
• W1998461265 hasConcept C126322002 @default.
• W1998461265 hasConcept C141071460 @default.
• W1998461265 hasConcept C142424586 @default.
• W1998461265 hasConcept C143998085 @default.
• W1998461265 hasConcept C2776364478 @default.
• W1998461265 hasConcept C2776694085 @default.
• W1998461265 hasConcept C2777478702 @default.
• W1998461265 hasConcept C2779609412 @default.
• W1998461265 hasConcept C2780401358 @default.
• W1998461265 hasConcept C2780775027 @default.
• W1998461265 hasConcept C2781413609 @default.
• W1998461265 hasConcept C31760486 @default.
• W1998461265 hasConcept C535046627 @default.
• W1998461265 hasConcept C71924100 @default.
• W1998461265 hasConcept C87355193 @default.
• W1998461265 hasConceptScore W1998461265C121332964 @default.
• W1998461265 hasConceptScore W1998461265C126322002 @default.
• W1998461265 hasConceptScore W1998461265C141071460 @default.
• W1998461265 hasConceptScore W1998461265C142424586 @default.
• W1998461265 hasConceptScore W1998461265C143998085 @default.
• W1998461265 hasConceptScore W1998461265C2776364478 @default.
• W1998461265 hasConceptScore W1998461265C2776694085 @default.
• W1998461265 hasConceptScore W1998461265C2777478702 @default.
• W1998461265 hasConceptScore W1998461265C2779609412 @default.
• W1998461265 hasConceptScore W1998461265C2780401358 @default.
• W1998461265 hasConceptScore W1998461265C2780775027 @default.
• W1998461265 hasConceptScore W1998461265C2781413609 @default.
• W1998461265 hasConceptScore W1998461265C31760486 @default.
• W1998461265 hasConceptScore W1998461265C535046627 @default.
• W1998461265 hasConceptScore W1998461265C71924100 @default.
• W1998461265 hasConceptScore W1998461265C87355193 @default.
• W1998461265 hasIssue "7" @default.
• W1998461265 hasLocation W19984612651 @default.
• W1998461265 hasLocation W19984612652 @default.
• W1998461265 hasOpenAccess W1998461265 @default.

• next